Foley Todd (CIK 1473930) reported 7 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-01-14). Recent activity: Buy AKTS (597,391 shares), Buy AKTS (2.7M shares), Buy AKTS (716,872 shares), Buy AKTS (232,870 shares), Sell ITOS (630,191 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-14 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 597,391 | $0 |
| 2026-01-14 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 2.7M | $0 |
| 2026-01-14 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 716,872 | $0 |
| 2026-01-14 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 232,870 | $4.2M |
| 2025-05-15 | iTeos Therapeutics, Inc. (ITOS) | Insider | Sell | 630,191 | $5.1M |
| 2025-04-30 | Werewolf Therapeutics, Inc. (HOWL) | Insider | Buy | 22,758 | $2,048 |
| 2025-04-30 | Werewolf Therapeutics, Inc. (HOWL) | Insider | Sell | 1,963 | $2,061 |
Source: SEC Form 4 filings · as of 2026-01-14